Hart worked with the state’s biotechnology industry leaders to establish BioNJ in 1994 and has been dedicated to building the state’s life sciences ecosystem ever since. Those efforts have been even more critical during the COVID-19 pandemic, with New Jersey situated squarely in the middle of both the outbreak and the fight to end it.
Hart was named by Gov. Phil Murphy to the New Jersey Commission on Science, Innovation and Technology and as co-chair of the Higher Education Strategic Plan Research, Innovation and Talent Working Group. She also served as chair of the bipartisan, bicameral Biotechnology Task Force which was charged with making recommendations to the Legislature for fostering the growth of the industry in New Jersey.
With New Jersey being the top biomanufacturing state in the country, BioNJ is taking an active role in assessing and promoting this growing sector, especially in the area of cell and gene therapy where New Jersey is leading the way from discovery through manufacturing.
Hart is a founding board member and officer of Opportunity NJ, a nonprofit working toward a strong and sustainable State economy and serves on the boards of the state Chamber of Commerce and Choose New Jersey.
She was named one of the world’s 100 Most Influential People in Biotechnology by Scientific American Worldview and to PharmaVOICE’s 2019 100 Most Inspiring People list and as one of New Jersey’s top CEOs by COMMERCE Magazine.